Wall Street analysts will be watching closely when Exelixis, Inc. (NASDAQ:EXEL) reports its quarterly earnings next, which is scheduled for Mon 25 Feb (In 43 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $0.31 per share. In the preceding quarter, the company reportedly generated EPS of $0.41 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 49.40%, a profit margin of 49.50% and a gross margin of 96.90%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of Exelixis, Inc. (NASDAQ:EXEL). Most recently, on September 17th, 2018, Goldman Initiated a Neutral rating. Before that, on September 10th, 2018, Morgan Stanley Initiated to Underweight. Needham Reiterated a Buy rating on May 11th, 2018, RBC Capital Mkts Reiterated an Outperform rating on October 17th, 2017, and Needham Reiterated a Buy rating on October 17th, 2017.
At its current price point, combined with the fact that this company has 302.88M shares outstanding, the current market capitalization sits at 7.20B. In the last trading day, 4,008,314 shares of Exelixis, Inc. were traded, which compares to its usual volume of about 4.36M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $3.03 in the past five trading days, resulting in a percentage change of +14.62% and a moving average of 23.34. In the past 20 days, its price changed by $1.96 (which is +8.99%) and the stock’s moving average was 20.52. Looking back a full 50 days, shares of EXEL changed by $10.11 (which is +74.07%) and demonstrated a moving average of 19.16.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 95.46%, a 14-day Stochastic %K score of 96.62% and a 20-day Stochastic %K score of 96.62%. Using a similar metric, Exelixis, Inc. (EXEL) shares showed a Stochastic %D of 96.80% over the past 9 days, a Stochastic %D score of 97.38% over the last 14 days, and a 20-day Stochastic %D of 96.63%. Meanwhile, this stock’s MACD Oscillator was 1.99 over the past 9 days, 3.16 over the past two weeks, and 3.32 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $23.76 level. Over the past 12 months, this stock has experienced a high price of $31.79 and a low of $13.42. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
BlackRock Fund Advisors purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from Exelixis, Inc. (NASDAQ:EXEL) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 27,749,354 shares of the company’s stock following the addition of 1,125,910 to this investor’s holdings during the three-month period. This share count represents that BlackRock Fund Advisors now held 9.28% stake in Exelixis, Inc. (EXEL)’s shares.
Just in the most recent trading day, Exelixis, Inc. (NASDAQ:EXEL) experienced a high price of $24.25 and low point of $23.37. At the end of the last trading session, this stock was at 23.76 per share, following a loss of -$0.13, or -1.29% during the full day.